Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
As CEO, I would not wait six months and I would not let the board delay disclosure while patients remain exposed to an unreported serious risk. I would treat this as a patient-safety, regulatory, legal, and trust crisis—not merely a financial-risk issue. My guiding decisions would be: Patient safety comes first.Read the full answer
Okay, the user is posing a high-stakes scenario as the CEO of a pharmaceutical company facing a serious drug safety issue. This is clearly a crisis management test that requires balancing multiple competing priorities. Hmm, the core tension here is between immediate patient safety versus corporate survival.Read the full answer